CNTA logo

Centessa Pharmaceuticals plc (CNTA) Cash From Operations

Annual CFO:

-$142.11M+$18.85M(+11.71%)
December 31, 2024

Summary

  • As of today, CNTA annual cash from operations is -$142.11 million, with the most recent change of +$18.85 million (+11.71%) on December 31, 2024.
  • During the last 3 years, CNTA annual cash from operations has fallen by -$5.97 million (-4.39%).

Performance

CNTA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

Quarterly CFO:

-$58.12M-$35.21M(-153.63%)
September 30, 2025

Summary

  • As of today, CNTA quarterly cash from operations is -$58.12 million, with the most recent change of -$35.21 million (-153.63%) on September 30, 2025.
  • Over the past year, CNTA quarterly cash from operations has dropped by -$36.31 million (-166.49%).
  • CNTA quarterly cash from operations is now -358.91% below its all-time high of -$12.67 million, reached on March 31, 2021.

Performance

CNTA Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

TTM CFO:

-$180.92M-$36.31M(-25.11%)
September 30, 2025

Summary

  • As of today, CNTA TTM cash from operations is -$180.92 million, with the most recent change of -$36.31 million (-25.11%) on September 30, 2025.
  • Over the past year, CNTA TTM cash from operations has dropped by -$50.12 million (-38.32%).
  • CNTA TTM cash from operations is now -1328.43% below its all-time high of -$12.67 million, reached on March 31, 2021.

Performance

CNTA TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CNTA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+11.7%-166.5%-38.3%
3Y3 Years-4.4%-52.1%+11.3%
5Y5 Years-2339.7%--

CNTA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-4.4%+29.1%-166.5%at low-38.3%+11.3%
5Y5-Year>-9999.0%+29.1%-358.9%+2.3%-1328.4%+11.3%
All-TimeAll-Time>-9999.0%+29.1%-358.9%+2.3%-1328.4%+11.3%

CNTA Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$58.12M(-153.6%)
-$180.92M(-25.1%)
Jun 2025
-
-$22.92M(+60.1%)
-$144.61M(+10.9%)
Mar 2025
-
-$57.47M(-35.5%)
-$162.32M(-14.2%)
Dec 2024
-$142.11M(+11.7%)
-$42.41M(-94.5%)
-$142.11M(-8.6%)
Sep 2024
-
-$21.81M(+46.3%)
-$130.80M(+10.6%)
Jun 2024
-
-$40.63M(-9.0%)
-$146.37M(+2.4%)
Mar 2024
-
-$37.26M(-19.8%)
-$149.96M(+6.8%)
Dec 2023
-$160.96M
-$31.10M(+16.8%)
-$160.96M(+11.8%)
Sep 2023
-
-$37.38M(+15.4%)
-$182.58M(+0.5%)
Jun 2023
-
-$44.21M(+8.4%)
-$183.42M(+7.7%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$48.27M(+8.4%)
-$198.70M(+0.9%)
Dec 2022
-$200.42M(-47.2%)
-$52.71M(-37.9%)
-$200.42M(+1.8%)
Sep 2022
-
-$38.22M(+35.8%)
-$204.00M(-2.5%)
Jun 2022
-
-$59.50M(-19.0%)
-$199.10M(-14.8%)
Mar 2022
-
-$49.99M(+11.2%)
-$173.47M(-27.4%)
Dec 2021
-$136.14M(>-9900.0%)
-$56.29M(-68.9%)
-$136.14M(-70.5%)
Sep 2021
-
-$33.32M(+1.6%)
-$79.85M(-71.6%)
Jun 2021
-
-$33.87M(-167.4%)
-$46.53M(-267.4%)
Mar 2021
-
-$12.67M
-$12.67M
Dec 2020
$0.00(+100.0%)
-
-
Dec 2019
-$5.83M
-
-

FAQ

  • What is Centessa Pharmaceuticals plc annual cash from operations?
  • What is the all-time high annual cash from operations for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc annual cash from operations year-on-year change?
  • What is Centessa Pharmaceuticals plc quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc quarterly cash from operations year-on-year change?
  • What is Centessa Pharmaceuticals plc TTM cash from operations?
  • What is the all-time high TTM cash from operations for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc TTM cash from operations year-on-year change?

What is Centessa Pharmaceuticals plc annual cash from operations?

The current annual cash from operations of CNTA is -$142.11M

What is the all-time high annual cash from operations for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high annual cash from operations is $0.00

What is Centessa Pharmaceuticals plc annual cash from operations year-on-year change?

Over the past year, CNTA annual cash from operations has changed by +$18.85M (+11.71%)

What is Centessa Pharmaceuticals plc quarterly cash from operations?

The current quarterly cash from operations of CNTA is -$58.12M

What is the all-time high quarterly cash from operations for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high quarterly cash from operations is -$12.67M

What is Centessa Pharmaceuticals plc quarterly cash from operations year-on-year change?

Over the past year, CNTA quarterly cash from operations has changed by -$36.31M (-166.49%)

What is Centessa Pharmaceuticals plc TTM cash from operations?

The current TTM cash from operations of CNTA is -$180.92M

What is the all-time high TTM cash from operations for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high TTM cash from operations is -$12.67M

What is Centessa Pharmaceuticals plc TTM cash from operations year-on-year change?

Over the past year, CNTA TTM cash from operations has changed by -$50.12M (-38.32%)
On this page